Arvinas, Inc. (ARVN) vs Contineum Therapeutics, Inc. (CTNM)
- Arvinas, Inc. ARVN 7.14 −4.16%
- Contineum Therapeutics, Inc. CTNM 8.70 +1.52%
Arvinas, Inc. and Contineum Therapeutics, Inc. are both Biotechnology companies. Arvinas, Inc. and Contineum Therapeutics, Inc. are of similar size ($503.4M and $499.6M). Contineum Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Arvinas, Inc. trades at 57.3×. Arvinas, Inc. has the higher net margin (2.94% vs 0.00%) and the higher return on invested capital (0.00% vs −1,334.4%). Across the 13 metrics below, Arvinas, Inc. leads on 7 and Contineum Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | ARVN | CTNM | Biotechnology median |
|---|---|---|---|
| Gross margin | 97.16% | — | 65.16% |
| Operating margin | (5.72%) | 0.00% | 0.00% |
| Net margin | 2.94% | 0.00% | 0.00% |
| Free cash flow margin | (65.93%) | 0.00% | 0.00% |
| Return on equity | 1.59% | (28.01%) | (56.66%) |
| Return on assets | 1.17% | (26.57%) | (49.22%) |
| Return on invested capital | 0.00% | (1,334.41%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack